Lee Biosolutions, Inc Company Profile

18:15 EDT 25th September 2017 | BioPortfolio

News Articles [42 Associated News Articles listed on BioPortfolio]

Emergent BioSolutions embarks on another spending spree

Shares of US biotech firm Emergent BioSolutions closed up 3.3% at $36.04 yesterday, after it announced…

Emergent Biosolutions (EBS) versus Theravance Biopharma (TBPHV) Head to Head Contrast

Theravance Biopharma and Emergent Biosolutions are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownershi...

Emergent BioSolutions buying rights to smallpox vaccine

Emergent BioSolutions has entered into an agreement to acquire the ACAM2000 (Smallpox [Vaccinia] Vaccine,…

Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab

Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.

Emergent BioSolutions To Buy ACAM2000 Business From Sanofi For Up To $125 Mln

PARIS (dpa-AFX) - Emergent BioSolutions Inc. (EBS) Friday announced that it has entered into an agreement to acquire the ACAM2000, (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi (SNYNF, SN...

Emergent Biosolutions acquires monoclonal antibody raxibacumab from GSK

Emergent BioSolutions Inc. bought rights to GlaxoSmithKline PLC's monoclonal antibody raxibacumab in an all-cash transaction.

Emergent BioSolutions gets global rights to Valneva's Zika vaccine technology

In its third deal this month, Emergent BioSolutions Inc. licensed exclusive worldwide rights to Valneva SE’s ZIKV Zika vaccine technology and know-how related to Zika drug development.

Emergent Biosolutions Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 02052017] Prices from USD $350

Emergent Biosolutions Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Emergent Biosolutions Inc. Mergers Acquisitions MA, Partnerships Alliances and ...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [11 Associated Companies listed on BioPortfolio]

Pantec Biosolutions AG

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:

Ocimum Biosolutions Ltd.

Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, Microarrays and Research services. The Microarray division of Ocimum has been recently acquired from MWG Biot...

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

DSM BioSolutions

Lee Biosolutions, Inc

More Information about "Lee Biosolutions, Inc" on BioPortfolio

We have published hundreds of Lee Biosolutions, Inc news stories on BioPortfolio along with dozens of Lee Biosolutions, Inc Clinical Trials and PubMed Articles about Lee Biosolutions, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lee Biosolutions, Inc Companies in our database. You can also find out about relevant Lee Biosolutions, Inc Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record